Literature DB >> 30087058

Surgical prevention strategies in ovarian cancer.

Adrianne Mallen1, T Rinda Soong2, Mary K Townsend3, Robert M Wenham1, Christopher P Crum4, Shelley S Tworoger5.   

Abstract

Given the current lack of effective screening for ovarian cancer, surgical removal of at-risk tissue is the most successful strategy to decrease risk of cancer development. However, the optimal timing of surgery and tissues to remove, as well as the appropriate patients to undergo preventive procedures are poorly understood. In this review, we first discuss the origin and precursors of ovarian epithelial carcinomas, focusing on high-grade serous carcinomas and endometriosis-associated carcinomas, which cause the majority of the mortality and incidence of ovarian cancer. In addition, we summarize the implications of current understanding of specific pathogenic origins for surgical prevention and remaining gaps in knowledge. Secondly, we review evidence from the epidemiologic literature on the associations of various surgical prevention strategies, including endometriosis excision, tubal procedures, and bilateral salpingo-oophorectomy, with risk of future ovarian cancer development, as well as the short- and long-term consequences of these strategies on women's health and quality and life. We conclude with recommendations for surgical prevention in women with high-risk genetic mutations and average-risk women, and a brief discussion of ongoing research that will help clarify optimal surgical approaches that balance risk-reduction with maintenance of women's quality of life.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Epidemiology; Ovarian cancer; Pathogenesis; Prevention; Surgery

Mesh:

Year:  2018        PMID: 30087058     DOI: 10.1016/j.ygyno.2018.08.005

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

Review 1.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

2.  A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients.

Authors:  Vera Loizzi; Ettore Cicinelli; Vittoria Del Vecchio; Francesca Arezzo; Xheni Deromemaj; Anila Kardhashi; Angelo Paradiso; Francesco Legge; Maria Iole Natalicchio; Leonardo Resta; Nicoletta Resta; Daria Carmela Loconte; Gennaro Cormio
Journal:  Acta Biomed       Date:  2022-08-31

3.  Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments.

Authors:  Lingling Gao; Xiao Li; Qian Guo; Xin Nie; Yingying Hao; Qing Liu; Juanjuan Liu; Liancheng Zhu; Limei Yan; Bei Lin
Journal:  Cancer Cell Int       Date:  2020-10-17       Impact factor: 5.722

4.  Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study.

Authors:  Chen-Yu Huang; Wen-Hsun Chang; Hsin-Yi Huang; Chao-Yu Guo; Yiing-Jenq Chou; Nicole Huang; Wen-Ling Lee; Peng-Hui Wang
Journal:  Clin Epidemiol       Date:  2020-06-18       Impact factor: 4.790

5.  High α B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer.

Authors:  Lin Tan; Ling Sha; Ning Hou; Mei Zhang; Qian Ma; Chuanbing Shi
Journal:  Biosci Rep       Date:  2019-06-18       Impact factor: 3.840

6.  Low BCL7A expression predicts poor prognosis in ovarian cancer.

Authors:  Ziqian Sun; Liang Sun; Miao He; Ying Pang; Zhaoying Yang; Junrong Wang
Journal:  J Ovarian Res       Date:  2019-05-10       Impact factor: 4.234

7.  Low EIF2B5 expression predicts poor prognosis in ovarian cancer.

Authors:  Lin Hou; Yan Jiao; Yanqing Li; Zhangping Luo; Xueying Zhang; Guoqiang Pan; Yuechen Zhao; Zhaoying Yang; Miao He
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

Review 8.  Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.

Authors:  Sandra Muñoz-Galván; Amancio Carnero
Journal:  Cells       Date:  2020-06-04       Impact factor: 6.600

9.  Ultrasound-Targeted Microbubble Destruction-Mediated Inhibition of Livin Expression Accelerates Ovarian Cancer Cell Apoptosis.

Authors:  Xiaolin Xu; Shuqin Yu; Xiaoyuan Liu; Ying Feng
Journal:  Genet Res (Camb)       Date:  2021-12-09       Impact factor: 1.588

10.  Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer.

Authors:  Chang Chen; Yali Xu; Xin Huang; Feng Mao; Songjie Shen; Ying Xu; Qiang Sun
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.